Disease/Infection News

RSS

Sensory loss strongly associated with COVID-19 infection

Loss of smell and taste has been anecdotally linked to COVID-19 infections. In a study published April 12, 2020 in the journal International Forum of Allergy & Rhinology, researchers at UC San Diego Health report the first empirical findings that strongly associate sensory loss with COVID-19, the respiratory disease caused by the novel coronavirus.

13 Apr 2020

Should infants be separated from coronavirus infected mothers?

Since the novel coronavirus infection emerged a couple of months ago, guidelines about its treatment and precautionary measures are still evolving based on evidence and research. For mothers and infants, there is contradicting information on whether they should be kept together or separated for fear of transmission.

13 Apr 2020

Ebola drug effective against key enzyme of coronavirus that causes COVID-19

Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research published today in the Journal of Biological Chemistry.

13 Apr 2020

Could DPP4 inhibitors help treat COVID-19?

Researchers and clinicians are scrambling to find ways to combat COVID-19, including new therapeutics and eventually a vaccine.

13 Apr 2020

New web-based tool examines community factors underlying COVID-19 outcomes

A new data visualization tool examines how and why COVID-19 impacts regions differently. Using daily updated data, COVIDMinder compares community risks, mediation tools, and outcomes related to COVID-19 by state across the United States, and by county within New York state.

13 Apr 2020

Columbia University launches CovidWatcher app to track virus spread in NYC

Researchers from Columbia University have launched CovidWatcher, an app that surveys users about their exposure to the new coronavirus, symptoms, access to medical care, and impact on daily life.

13 Apr 2020

Re-thinking the built environment to limit coronavirus transmission

The coronavirus disease (COVID-19) global pandemic has taken a toll on many countries across the globe. The hardest-hit countries are now grappling to contain the spread of various through social distancing measures, while others are now in total lockdown.

13 Apr 2020

How does COVID-19 attack the body?

The coronavirus disease (COVID-19) attacks the lungs, leading to pneumonia, and eventually, a cascade of serious complications. But how does COVID-19 kill? Is it the virus itself or the result of the person’s immune system response?

13 Apr 2020

Extend lockdowns to stave off second wave of COVID-19

Social distancing, keeping people at home, and lockdowns are being implemented in many nations to prevent the spread of the highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some countries that have seen declines in the number of new infections due to lockdowns are now looking to allow people to return to more normal daily routines.

13 Apr 2020

Cost of ‘repurposing’ existing drugs to treat COVID-19

The paper looks at repurposed drugs that might demonstrate efficacy against COVID-19, and if they could be manufactured profitably at very low costs to ensure affordable access to vital treatments for COVID-19 at low prices globally.

13 Apr 2020

Monitoring loss of smell could be key to COVID-19 detection

Researchers have found that persons who test positive for COVID-19 disease have common symptoms, including fever, cough, shortness of breath, and a temporary loss of the sense of smell.

13 Apr 2020

Missing COVID-19 antibodies suggest mystery immune response

Researchers at Shanghai Public Health Clinical Center have made important discoveries about the immune response among patients who have recovered from mild COVID-19 disease that could help to inform prevention and treatment methods, as well as improve the efficacy of community testing.

13 Apr 2020

WVU researchers develop viable alternatives to N95 masks

The novel coronavirus pandemic has nearly exhausted stockpiles of medical gear in the United States. Personal protective equipment, like masks, serve as a first-line defense for medical professionals with a front row seat to COVID-19.

13 Apr 2020

Sanders: In coronavirus relief effort, Congress fell short on paid sick leave

The pressure is building for Congress to pass a fourth coronavirus relief bill, beyond the roughly $2.2 trillion already approved to keep people and businesses viable during an unprecedented viral attack.

13 Apr 2020

UChicago Medicine launches clinical trial to explore plasma transfusions for COVID-19 patients

The University of Chicago Medicine is launching a clinical trial to study whether blood plasma from people who have recovered from COVID-19 can be used to treat patients who are still in the hospital with severe disease symptoms.

13 Apr 2020

FDA approves new Rutgers saliva test for coronavirus

The FDA has granted emergency use authorization to Rutgers' RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.

13 Apr 2020

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.

13 Apr 2020

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs - hydroxychloroquine and azithromycin - to treat patients with COVID-19.

13 Apr 2020

Large-scale analysis links glucose metabolism proteins to Alzheimer's disease biology

A team has identified Alzheimer's disease-specific proteins and processes that could be used for treatment targets and biomarkers.

13 Apr 2020

Remdesivir shows promise in post-infection treatment for COVID-19 disease

The coronavirus disease (COVID-19) has no approved treatment or vaccine as the world grapple with its wrath. The viral infection has so far infected 1.8 million and killed more than 114,000 people. Now, a team of scientists has shown that an experimental antiviral drug, remdesivir, has shown promise in treating patients with severe COVID-19.

13 Apr 2020